April 18, 2025 - 00:45

In another significant legal blow to Google, a federal judge on Thursday ruled that the search giant held an illegal monopoly over certain advertising technology. This decision comes as part of an ongoing scrutiny of Google's practices in the digital advertising space, raising concerns about competition and consumer choice.
The ruling asserts that Google's dominance in the online advertising market has stifled competition, allowing the company to control prices and limit options for advertisers and publishers alike. The judge's findings highlight the impact of Google's practices on smaller competitors, who struggle to gain a foothold in a market heavily influenced by the tech giant's extensive resources and reach.
This ruling could have far-reaching implications for the future of online advertising and may pave the way for increased regulatory scrutiny of other tech companies as well. As the legal proceedings continue, the case serves as a critical examination of monopolistic practices in the rapidly evolving digital landscape.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...